Canagliflozin side effects by duration, gender and age - a phase IV clinical study of FDA data


Side effects are reported by people who take Canagliflozin. Common side effects include diabetic ketoacidosis among females and diabetic ketoacidosis among males.

The phase IV clinical study is created by eHealthMe based on 2,308 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 24, 2022

2,308 people who take Canagliflozin and have side effects are studied.

What is Canagliflozin?

Canagliflozin has active ingredients of canagliflozin. eHealthMe is studying from 2,308 Canagliflozin users for its effectiveness, alternative drugs and more.

Number of Canagliflozin reports submitted per year:

Canagliflozin side effects.

Canagliflozin side effects by time on the drug *:

Click here to view

Canagliflozin side effects by gender *:

Click here to view

Canagliflozin side effects by age *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Canagliflozin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study is based on canagliflozin (the active ingredients of Canagliflozin) and Canagliflozin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Canagliflozin:

Common Canagliflozin side effects:

All Canagliflozin side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: